• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: dbr:Fondaparinux     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : umbel-rc:DrugProduct, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingdul:ChemicalObjectchemical substanceDrugyago:WikicatSaltsAndEstersOfCarboxylicAcidsyago:WikicatSodiumCompoundsyago:WikicatSulfonicAcidsyago:Abstraction100002137yago:Acetal114710805yago:Acid114607521yago:Agent114778436yago:Anticoagulant102718259yago:Carbohydrate114792703yago:CausalAgent100007347yago:Chemical114806838yago:Cognition100023271yago:Compound105870180yago:Compound114818238yago:Concept105835747yago:Content105809192yago:Drug103247620yago:Heparin103514974yago:Idea105833840yago:LanguageUnit106284225yago:Macromolecule114944888yago:Material114580897yago:Matter100020827yago:Medicine103740161yago:Molecule114682133yago:Name106333653yago:OrganicCompound114727670yago:Part113809207yago:PhysicalEntity100001930yago:Polysaccharide114994004yago:PsychologicalFeature100023100yago:Relation100031921yago:WikicatGlaxoSmithKlineBrandsyago:WikicatHeparinsdrugyago:Salt115010703yago:Substance100019613yago:Substance100020090yago:SulfonicAcid114616508yago:Thing100002452yago:TradeName106845599yago:Unit109465459yago:Whole105869584yago:WikicatAcetalsyago:WikicatPolysaccharidesumbel-rc:DrugProduct New Facet based on Instances of this Class

Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by GlaxoSmithKline. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories.